This newsletter presents you the following key sessions:
1. Podcast with Prof. Bruno Sangro about the four-year overall survival update from the phase III HIMALAYA
study
2. Podcast with Dr. Anna Dorothea Wagner about the integration of trastuzumab, with or without pertuzumab,
into perioperative chemotherapy of HER2-positive gastric cancer
3. Podcast with Dr. Monica Niger about the clinical relevance and actionability of BRAF alterations in advanced
biliary tract cancer
4. Podcast with Marjolein Lansbergen about a transcriptome-based classification to predict FOLFIRINOX
response in a real-world metastatic pancreatic cancer cohort